USADA has officially issued a year-long suspension to Jesse Taylor after the 34-year-old tested positive for clomiphene, an anti-estrogen agent and banned substance.
“Increasing testosterone, especially when combined with strength training, has been demonstrated to increase fat-free mass, muscle size, and strength in males, potentially leading to performance enhancement in sport,” reads the formal statement regarding the matter, per MMAFighting.com.
The failed drug test stems from an out-of-competition sample collected on August 22. The UFC had already rescinded Taylor’s spot on the UFC Fight Night 121 card in Sydney on November 18 as well. Taylor, a native of Poway, California was originally slated to take on Belal Muhammad next month.
Should he remain in the USADA drug-testing pool, Taylor will be eligible to return to action on September 13, 2018.
Taylor (31-15) has alternated wins and losses over his last four tilts, the most recent victory a submission over Dhiego Lima on The Ultimate Fighter: Redemption Finale. Of the 31 wins during his career, 17 have come via submission. Taylor has been all over the map, fighting in places such as Wales, Ireland, Argentina, Bahrain, Poland and Mexico — among a bevy of locations outside the United States.
UFC Fight Night 121 in Sydney, which is right around the corner, will be centered around a heavyweight bout between Fabricio Werdum and Marcin Tybura. Not to be outdone, Bec Rawlings versus Joanne Calderwood (women’s flyweight), Alex Volkanovski versus Jeremy Kennedy (featherweight) and Dan Kelly versus Elias Theodorou (middleweight) will also be featured on the upcoming card.